Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.

Authors

Jessica I Gold, Center for Translational Medicine, Thomas Jefferson University, School of MedicineFollow
Erhe Gao, Center for Translational Medicine, Temple University School of MedicineFollow
Xiying Shang, Center for Translational Medicine, Temple University School of MedicineFollow
Richard T Premont, Department of Medicine, Duke University Medical Center
Walter J Koch, Center for Translational Medicine, Thomas Jefferson University, School of Medicine; Center for Translational Medicine, Temple University School of Medicine; Department of Pharmacology, Temple University School of MedicineFollow

Document Type

Article

Publication Date

9-28-2012

Comments

This article has been peer reviewed and is published in Circulation Research.

Volume 111, Issue 8, September 2012, Pages 1048-1053.

The published version is available at DOI: 10.1161/CIRCRESAHA.112.273367. © 2012 American Heart Association, Inc.

Abstract

RATIONALE: Heart failure (HF) is often the end phase of maladaptive cardiac hypertrophy. A contributing factor is activation of a hypertrophic gene expression program controlled by decreased class II histone deacetylase (HDAC) transcriptional repression via HDAC phosphorylation. Cardiac-specific overexpression of G proteinen-coupled receptor kinase-5 (GRK5) has previously been shown to possess nuclear activity as a HDAC5 kinase, promoting an intolerance to in vivo ventricular pressure overload; however, its endogenous requirement in adaptive and maladaptive hypertrophy remains unknown.

OBJECTIVE: We used mouse models with global or cardiomyocyte-specific GRK5 gene deletion to determine the absolute requirement of endogenous GRK5 for cardiac hypertrophy and HF development after chronic hypertrophic stimuli.

METHODS AND RESULTS: Mice with global deletion of GRK5 were subjected to transverse aortic constriction. At 12 weeks, these mice showed attenuated hypertrophy, remodeling, and hypertrophic gene transcription along with preserved cardiac function. Global GRK5 deletion also diminished hypertrophy and related gene expression due to chronic phenylephrine infusion. We then generated mice with conditional, cardiac-specific deletion of GRK5 that also demonstrated similar protection from pathological cardiac hypertrophy and HF after transverse aortic constriction.

CONCLUSIONS: These results define myocyte GRK5 as a critical regulator of pathological cardiac growth after ventricular pressure overload, supporting its role as an endogenous (patho)-physiological HDAC kinase. Further, these results define GRK5 as a potential therapeutic target to limit HF development after hypertrophic stress.

Recommended Citation

Gold, Jessica I; Gao, Erhe; Shang, Xiying; Premont, Richard T; and Koch, Walter J, "Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication." (2012). Center for Translational Medicine Faculty Papers. Paper 13.
https://jdc.jefferson.edu/transmedfp/13

PubMed ID

22859683